• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Investigation of microRNA interaction between pancreatic cancer cells and the stromal cells aiming to overcome the resistance to chemotherapeutic drugs.

Research Project

Project/Area Number 25462111
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Digestive surgery
Research InstitutionOsaka University

Principal Investigator

Eguchi Hidetoshi  大阪大学, 医学(系)研究科(研究院), 准教授 (90542118)

Co-Investigator(Kenkyū-buntansha) WADA Hiroshi  大阪大学, 大学院医学系研究科, 助教 (00572554)
HAMA Naoki  独立行政法人国立病院機構, 大阪医療センター(臨床研究センター), 研究員 (00645723)
NAGANO Hiroaki  山口大学, 医学系研究科, 教授 (10294050)
KAWAMOTO Kouichi  大阪大学, 大学院医学系研究科, 助教 (30432470)
KOBAYASHI Syougo  地方独立行政法人大阪府立病院機構, 大阪府立成人病センター, その他 (30452436)
HASEGAWA Shinichirou  大阪大学, 医学部付属病院, その他 (60621026)
AKITA Hirofumi  地方独立行政法人大阪府立病院機構, 大阪成人病センター, その他 (70528463)
Project Period (FY) 2013-04-01 – 2016-03-31
Project Status Completed (Fiscal Year 2015)
Budget Amount *help
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2015: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2014: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2013: ¥1,690,000 (Direct Cost: ¥1,300,000、Indirect Cost: ¥390,000)
KeywordsmicroRNA / 癌間質 / エクソソーム / 薬剤耐性 / 膵癌
Outline of Final Research Achievements

We established gemcitabine-resistant pancreatic cancer cells, and miR-320c was selected as a responsible miRNA for the drug-resistance by microarray analysis between the resistant cells and its parental cells. Among the target genes for miR-320c, SMARCC1 was investigated by immunohistochemistry, and was shown to have a positive correlation to a better survival.
Exosomes derived from pancreatic cancer cells cultured in a hypoxic condition was added to human dermal fibroblasts (HDFs), and the expression level of α-SMA in HDFs was more obviously increased than the exosomes derived from cells cultured in normal condition. Moreover, the addition of HDFs with increased α-SMA to another pancreatic cancer cells has shown to increase the growth rate and invasiveness.

Report

(3 results)
  • 2015 Annual Research Report   Final Research Report ( PDF )
  • 2013 Research-status Report
  • Research Products

    (4 results)

All 2015 2013

All Journal Article (1 results) (of which Peer Reviewed: 1 results) Presentation (3 results)

  • [Journal Article] miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1.2013

    • Author(s)
      Iwagami Y, Eguchi H, Nagano H, Akita H, Hama N, Wada H, Kawamoto K, Kobayashi S, Tomokuni A, Tomimaru Y, Mori M, Doki Y.
    • Journal Title

      Br J Cancer

      Volume: 109(2) Issue: 2 Pages: 502-511

    • DOI

      10.1038/bjc.2013.320

    • Related Report
      2013 Research-status Report
    • Peer Reviewed
  • [Presentation] 低酸素下における膵癌細胞由来エクソソームが癌細胞の悪性度に与える影響2015

    • Author(s)
      三賀森学、江口英利、他
    • Organizer
      第70回 日本消化器外科学会
    • Place of Presentation
      浜松
    • Year and Date
      2015-07-16
    • Related Report
      2015 Annual Research Report
  • [Presentation] 膵癌細胞株におけるエクソソームを介した薬剤耐性獲得機構の解明2015

    • Author(s)
      三賀森学、江口英利、他
    • Organizer
      第115回 日本外科学会
    • Place of Presentation
      名古屋
    • Year and Date
      2015-04-18
    • Related Report
      2015 Annual Research Report
  • [Presentation] 膵癌細胞株におけるgemcitabine耐性を制御するmicroRNAの同定と機能解析2013

    • Author(s)
      岩上佳史、江口英利、他
    • Organizer
      第113回日本外科学会
    • Place of Presentation
      福岡市
    • Related Report
      2013 Research-status Report

URL: 

Published: 2014-07-25   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi